Acid Ceramidase: A Novel Therapeutic Target in Cancer

(E-pub Ahead of Print)

Author(s): Yadu Vijayan, Manendra Babu Lankadasari, Kuzhuvelil B. Harikumar*.

Journal Name: Current Topics in Medicinal Chemistry

Become EABM
Become Reviewer


Sphingolipids are important constituents of eukaryotic cell membrane which govern various signaling pathways related to different aspects of cell survival. Ceramide and Sphingosine are inter convertible sphingolipid metabolites, out of which Ceramide is pro-apoptotic and sphingosine is anti-apoptotic in nature. The conversion of ceramide to sphingosine is mediated by Acid Ceramidase (ASAH1) thus maintaining a rheostat between a tumor suppressor and a tumor promoter. This rheostat is completely altered in many tumors leading to uncontrolled proliferation. This intriguingproperty of ASAH1 can be used by cancer cells to their advantage, by increasing the expression of the tumor promoter, sphingosine inside cells, thus creating a favorable environment for cancer growth. The different possibilities through which this enzyme serves its role in formation, progression,and resistance of different types of cancers will lead to the possibility of making Acid Ceramidase a promising drug target. This review discusses the current understanding on the role of acid ceramidase in cancer progression, metastasis and resistance, strategies to develop novel natural and synthetic inhibitors of ASAH1 and their usefulness in cancer therapy.

Keywords: Acid ceramidase, sphingosine, cancer, metastasis, chemotherapy, radiation.

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1568026619666190227222930
Price: $95